A Long December (…and why cancer returns.)
“And it’s been a long December and there’s reason to believe, maybe this year will be better than the last. I can’t remember all the times I tried to tell my myself, to hold on to these moments as they pass.” | Counting Crows – from the 1996 album, Recovering the Satellites.
It’s been a long December for me personally. It seems it was one client crisis and complication after another.
In order to understand Why Cancer Returns (an individual coming out of remission) we first need to appreciate the Second Biological Law of German New Medicine – simply stated, the law of two phases. Every disease unfolds with a conflict active and healing phase (assuming a conflict resolution has been reached.)
The conflict active phase is dominated by what is termed sympathicotonia – the cold phase of the sympathetic nervous system, while the healing phase is dominated by what is termed vagotonia – the warm phase of the parasympathetic nervous system.
As we have discussed, some biological programs (cancers) show tissue augmentation during the conflict active phase, while others only during the resolution or healing phase.
During a conflict active phase, there are times when an increase (surplus) of tissue is required. We see this, for example with a pancreatic program (pancreatic adenocarcinoma.) During conflict activity cell augmentation (tumor) initiates, its meaningful purpose – to produce an abundance of pancreatic enzymes in order to accept, digest or come to terms with the indigestible anger ‘morsel.’ With more tissue, more pancreatic enzymes can be produced in order to digest the morsel.
There are times when less tissue will be beneficial. Staying with the pancreas, when one experiences a territorial anger with respect to something that was stolen or being ripped off – they may experience that situation as a specific biological conflict associated with the pancreatic duct. In this particular situation, tissue loss in the pancreatic duct will occur. The biological meaning is revealed during this time of conflict activity as the ulcerative widening (tissue loss) in the pancreatic duct facilitates a more efficient transportation of digestive secretions needed to breakdown the figurative ‘morsel’ that was removed, taken, stolen or ripped off. When the biological conflict is resolved, the loss of tissue is replenished with rapidly dividing cells (cancer.)
We are presented with four distinct possibilities.
Surgery. If a surgical procedure is performed, (e.g. a breast lumpectomy) before the tissue augmentation cycle of the biological program has come to completion – the program will continue it’s expression and unfold to it’s natural conclusion on both the organ and cerebral levels. This is a timing issue that can only be harnessed with an understanding of the Five Biological Laws of German New Medicine. Remember, it is the psyche that is driving the bus. Weeks or months later those very cells will be identified on a scan and you’ll be told the cancer has returned or the surgeon didn’t get ‘wide enough margins’ of the tissue.
Chemotherapy. A client with a tibial sarcoma (bone cancer of the arm) had been through chemotherapy and everything was looking good. A couple of months later the sarcoma returned and was now, according to the oncologist, growing rapidly and with a great aggressiveness. A sarcoma program (bone cancer) will demonstrate cell loss during the conflict active or sympathicotonic phase of the biological program. If the conflict was still active when the chemotherapy was administered – the cancer will “return” six to eight weeks after the chemo has left the body. In actuality, nothing is “returning”, rather the expression of the natural biological program was affected by the treatment, but with an adverse complicating twist … chemotherapy is sympathicotonic, so the treatment will interrupt or suspend the healing phase by inducing a deeper state of sympathicotonia. If the sarcoma conflict was still active (sympathicotonia) when the chemotherapy was initiated, the chemotherapy will deepen the conflict active phase. When the chemotherapeutic agents leave the body, the healing phase recommences but with a rebound effect due to this amplified sympathicotonia. As the biological program starts up again with an intensified expression – this is interpreted by traditional oncology as an “aggressive” return of the cancer. Sadly, we see this over and over again.
This observation applies to radiation therapy as well. Any targeted therapy must be utilized within this context, otherwise it’s hit-or-miss and sheer luck if success is achieved. It should be noted that *steroids are often administered during chemotherapy – this is a double whammy (I know, I know – not very technical) as the steroid has the same effect as described above.
Relapses. A third possibility has to do with tracks – triggers or subconscious reminders that can put us back into conflict active and or healing phase physiology. In the case of any fully resolved biological program (cancer), anytime that individual experiences a track – the cell augmentation, cell replenishment may recommence. With chronic relapse, when enough conflict mass (tissue) accumulates – weeks, months or even years later those very cells will be identified on a scan and you’ll be told the cancer has reappeared.
This is why I harp, ad nauseum, with clients on identify and eliminating these tracks.
New Conflicts. Finally, we can experience a brand new conflict in the same organ that may be misinterpreted as coming out of remission.
In the case of a cancer “returning” to different parts of the body – the standard medicine tells us that a primary cancer has returned and has now spread to a secondary and tertiary organ. This is commonly known as the theory of metastasis. Yet, even the standard medicine admits the mechanisms are not completely understood. Metastasis in the conventional sense cannot exist in light of The Five Biological Laws but rather is related to new conflict-shocks.
*It is for this very reason that activity of the kidney collecting tubules are amplified through chemotherapeutic agents or any agent, such as steroids – that amplifies sympathicotonia.
Hopefully, Dr. Hamer’s research observations will induce an open conversation between you and your physician. If your doctor is congruent with these observations then, and only then, can those involved formulate a course of action. Please make sure that your oncology team agrees with these observations before making any final personal health decisions. It’s that important.
This German New Medicine blog is an educational only blog. The information and services contained herein should not be construed as a diagnosis, treatment, prescription or cure for disease. Those seeking treatment for a specific disease should consult with their physician in order to determine the proper, correct and accepted treatment protocol before using anything that is disclosed on this page. Please visit our Legal page for more information.